Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 7Thyroid Nodule 1Pancreatic Cystic Neoplasm 1Malignant Non-small Cell Neoplasm of Lung Stage Ia 1Malignant Liver Neoplasm 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Bone Cancer Metastatic 1Biliary Tract Neoplasms 1

Interventions

Sunitinib 26Everolimus 20Bevacizumab 19aldesleukin 18Sorafenib 16Nivolumab 16Interleukin-2 14pembrolizumab 13Peripheral Blood Stem Cell Transplantation 13fludarabine phosphate 12Radiotherapy 12Interferon-alpha 12Cyclophosphamide 12Radiosurgery 11Filgrastim 11Blood Specimen Collection 11Ipilimumab 10Gemcitabine 10Axitinib 9Surveys and Questionnaires 7Gene Expression Profiling 7Cryosurgery 7temsirolimus 6pazopanib 6Surgical Procedures, Operative 6durvalumab 5cabozantinib 5atezolizumab 5Mycophenolic Acid 5Immunohistochemistry 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Kidney Neoplasms × Catheter Ablation × Clear all
NCT01608165 2015-12-07

CONSERVE

Newcastle-upon-Tyne Hospitals NHS Trust

Phase NA Completed
17 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡